BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Jan. 12, 2015
View Archived Issues
InVivo reopens enrollment for Neuro-Spinal Scaffold
InVivo Therapeutics (Cambridge, Massachusetts) reported the reopening of subject enrollment for the company's ongoing pilot trial of its investigational Neuro-Spinal Scaffold in patients with acute spinal cord injury.
Read More
It's Complicated: Genome studies broaden and deepen as methods progress
Read More
FDA grants CLIA waiver for molecular diagnostic test for influenza A & B
Read More
Inside the Beltway: Palmetto's Putcha: FDA oversight of LDTs could push testing to clinics
Read More
Attached to today's issue: The MDD 4Q Report.
Read More
Financings: PureTech closes on $50 million growth stage investment round
Read More
Report from Europe; Mauna Kea reports its sales are up 10% despite 'sharply contrasting trends'
Read More
HIT Bits: Mirth to power patient health information for Arizona network
Read More
MDD's Stock Market Winners and Losers
Read More
MDD's Stock Report for the week of 1/2-1/9
Read More
Briefly noted
Read More
People in Places
Read More
Product briefs
Read More
MDD's Neurology Extra
Read More
MDD's 4Q Report: Mergers and Acquisitions: Fewer, but more valuable, deals are the trend for last quarter of 2014
Read More
4Q14 Deals Chart
Read More
MDD's 4Q Report: Financings: Series A funding and IPOs show steady resolve in 4Q14
Read More
4Q14 Financial Chart
Read More
MDD's 4Q Report: Inside the Beltway FDA publishes revised draft guidance for LDT regulation
Read More
MDD's 4Q Report: Agreements/contracts: End of year slows down a bit, but still sees quality partnerships
Read More
